Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 3/20 | 0.51 |
| ▸ | ATRIP | Q8WXE1 | 1/20 | 0.51 |
| ▸ | MTOR | P42345 | 17/20 | 0.41 |
| ▸ | FECH | P22830 | 1/20 | 0.41 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | RICTOR | Q6R327 | 1/20 | 0.41 |
| ▸ | RPTOR | Q8N122 | 1/20 | 0.41 |
| ▸ | MAPKAP1 | Q9BPZ7 | 1/20 | 0.41 |
| ▸ | MLST8 | Q9BVC4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23780785 | 1.00 | ATR (0.51) | ATRATRIPMTORFECHPIK3R1 | |
| SCHEMBL23780784 | 1.00 | ATR (0.51) | ATRATRIPMTORFECHPIK3R1 | |
| SCHEMBL23780781 | 0.91 | ATR (0.51) | ATRATRIPMTOR | |
| SCHEMBL29678485 | 0.91 | ATR (0.51) | ATRATRIPMTOR | |
| SCHEMBL23780779 | 0.91 | ATR (0.51) | ATRATRIPMTOR | |
| SCHEMBL29678436 | 0.88 | ATR (0.49) | ATRATRIPMTORPIK3CA | |
| SCHEMBL23780759 | 0.88 | ATR (0.49) | ATRATRIPMTORPIK3CA | |
| SCHEMBL23780760 | 0.88 | ATR (0.49) | ATRATRIPMTORPIK3CA | |
| SCHEMBL25791130 | 0.87 | ATR (0.49) | ATRATRIPMTOR | |
| SCHEMBL23780755 | 0.86 | ATR (0.48) | ATRATRIPMTORPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114174292-B | Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors | 修复治疗公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-4003993-A1 | SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS | Repare Therapeutics Inc. (CA) | 2022-06-01 | — | — | EP | disclosed |